Pharmacy Report Archives - Page 56 of 151 - Becker's Hospital Review

Med spas, fake Ozempic worry clinicians | Popular inhaler faces discontinuation | Rite Aid barred from using facial recognition | Ill. hospital suspends CEO

January 2, 2024 BHR Newsletter 1. Clinicians warn of infection risks tied to med spas Full story 2. Fake Ozempic poses infection risk: FDA Full story 3. Rite Aid barred from using facial recognition for 5 years Full story 4.…

12 new drug shortages | Pharmacist pay by state | Nearly 3,000 overdosed on Ozempic, Wegovy in 2023 | 10 systems seeking pharmacy leaders | UC San Diego refines acne vaccine

December 21, 2023 BHR Newsletter 1. Average pay for pharmacists, state by state Full story 2. 12 drugs now in shortage Full story 3. Scientists at UC San Diego refine acne vaccine Full story 4. IT costs are skyrocketing, and community…

Older weight loss drugs regain popularity | Where pharmacists, techs are paid most | Cough stigma ups cold medicine use | Workers want 'quiet management' | PBMs ranked by market share

December 20, 2023 BHR Newsletter 1. Older weight loss drugs rise in popularity in Ozempic era Full story 2. Where pharmacists, pharmacy techs are paid most Full story 3. Workers want 'quiet management' Full story 4. This Kansas system boosted…

CareFirst sues J&J | DEA fights Ga. pharmacies' plan to offer cannabis | How low drug prices spur shortages | 3 CAR-T drugs on clinical hold | 2 Pa. systems to merge

December 19, 2023 BHR Newsletter 1. How races to the bottom spur drug shortages Full story 2. Feds warn Georgia against allowing pharmacies to dispense marijuana Full story 3. CareFirst sues J&J over alleged anticompetitive biosimilar tactics Full story 4.…

13 of 20 popular drugs in shortage | Mark Cuban, 4th PBM partner | Ill. hospital diverts 6 tons of IV bag waste | Don't skip Ozempic: UCLA Health expert | 25 largest systems by physicians

December 18, 2023 BHR Newsletter 1. UCLA Health expert: Don't skip Ozempic for the holidays Full story 2. Mark Cuban Cost Plus Drugs teams up with 4th PBM company Full story 3. 13 of 20 most popular drugs are in…

Pediatricians wary of doling out Wegovy | Supreme Court to review abortion pill case | A rundown of the big 6 payers + their PBMs | 10 systems seeking pharmacy leaders | Emory leaves hospital CEO spot vacant

December 14, 2023 BHR Newsletter 1. Pediatricians hesitant to prescribe Wegovy Full story 2. Supreme Court to hear case on mifepristone Full story 3. Vaccine therapy from Merck, Moderna may cut risk of skin cancer recurrence in half Full story 4.…

Weight loss drugs fuel spike in poison center calls | Congress scrutinizes pharmacy chains' record-sharing | AstraZeneca inks $1B deal for vaccine co. | The layoff runway lengthens | Moderna exec steps down

December 13, 2023 BHR Newsletter 1. Pharmacies share customer records with police without a warrant: Congressional probe Full story 2. Poison control centers see surge in calls about weight-loss drugs Full story 3. AstraZeneca to buy vaccine company for $1.1B Full…

10 most responsible drugmakers | Pfizer donates cancer drug rights | The cost of 'unsupported' drug price hikes | Beth Israel Lahey restructures execs | Walmart pilots in-store mammograms

December 12, 2023 BHR Newsletter 1. 'Unsupported' drug price increases cost payers $1.3B: ICER Full story 2. Pfizer donates rights to cancer drug Full story 3. 10 drugmakers on Newsweek's list of most responsible healthcare companies Full story 4. How does…

Hospitals offer new CRISPR therapy | 8 influential drug approvals in '23 | Walgreens expands COVID, flu services | Pharmacist to pay $573K for fraud | Fla. ERs face new rules

December 11, 2023 BHR Newsletter 1. 9 hospitals cleared to deliver new CRISPR-based sickle cell treatment Full story 2. 8 most influential drug approvals in 2023: GoodRx Full story 3. Walgreens expands testing, treatment options for COVID-19, flu Full story…

From pharmacist to hospital CEO: 2 paths | US targets drug patents | Why retail pharmacists are protesting | 10 systems seeking pharmacy leaders | Millions of syringes in limbo

December 7, 2023 BHR Newsletter 1. Biden administration OKs ability to seize drug patents to lower costs Full story 2. Why non-union pharmacists are protesting Full story 3. How 2 pharmacy leaders became hospital CEOs Full story 4. How does your…